08 Dec
Top 10 Most Expensive Chronic Diseases in the US
Chronic diseases and their expensive treatments are the most important factors driving soaring healthcare expenditures in the global healthcare industry. As the world’s largest healthcare market and highest healthcare spending
30 Aug
Top 5 Oncology Drugs in the Global Pharmaceutical Industry (2017)
Oncology drugs is one of the fastest-growing segments in the global pharmaceutical industry. Over the next five years, oncology drug sales are expected to exceed USD 90 billion—a staggering number
25 Aug
Novartis Expands Cancer Drugs Portfolio as Kisqali Receives EU Approval
The newest of Novartis’s cancer drugs, Kisqali, has received European Union approval. Kisqali will be used as a first-line treatment for a difficult-to-treat breast cancer. The company expects Kisqali to be a
24 Aug
Top 10 Oncology Drugs Companies (2017)
With cancer rates on the rise, oncology drugs are more valuable and necessary now than ever before. For pharmaceutical companies, oncology drugs are guaranteed to generate revenue—and for patients, oncology
21 Jun
Cancer Will Affect One in Every Two Canadians in Their Lifetime, Says New Report
Cancer will soon become the leading cause of death in Canada. A new report by the Canadian Cancer Society (CCS) predicts that one in every two Canadians will be diagnosed
